Depletion of M2-Like Tumor-Associated Macrophages Delays Cutaneous T-Cell Lymphoma Development In Vivo
- 1 November 2014
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 134 (11), 2814-2822
- https://doi.org/10.1038/jid.2014.206
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populationsLeukemia & Lymphoma, 2013
- Macrophage plasticity and polarization: in vivo veritasJCI Insight, 2012
- Immunohistochemical markers for tumor associated macrophages and survival in advanced classical Hodgkin's lymphomaHaematologica, 2012
- Upregulation of Inflammatory Cytokines and Oncogenic Signal Pathways Preceding Tumor Formation in a Murine Model of T-Cell Lymphoma in SkinJournal of Investigative Dermatology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Sézary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviorsBlood, 2010
- Transcriptional Profiles Predict Disease Outcome in Patients with Cutaneous T-Cell LymphomaClinical Cancer Research, 2010
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaThe New England Journal of Medicine, 2010
- Alternative Activation of Macrophages: An Immunologic Functional PerspectiveAnnual Review of Immunology, 2009
- Cancer-related inflammationNature, 2008